BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14633174)

  • 1. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
    Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
    J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D; He Q; Chen Y; Wang L; Zhang X
    J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
    Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
    Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
    Witzigmann H; Geissler F; Benedix F; Thiery J; Uhlmann D; Tannapfel A; Wittekind C; Hauss J
    Surgery; 2002 Jan; 131(1):34-43. PubMed ID: 11812961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
    Lemoine A; Le Bricon T; Salvucci M; Azoulay D; Pham P; Raccuia J; Bismuth H; Debuire B
    Ann Surg; 1997 Jul; 226(1):43-50. PubMed ID: 9242336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
    Marubashi S; Nagano H; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2011 Aug; 18(8):2200-9. PubMed ID: 21301972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
    Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
    Ijichi M; Takayama T; Matsumura M; Shiratori Y; Omata M; Makuuchi M
    Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
    Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG
    Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.